Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001182639 | SCV001348152 | likely benign | Cardiomyopathy | 2019-05-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000952047 | SCV001777829 | likely benign | not provided | 2020-10-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002066304 | SCV002442932 | likely benign | Hypertrophic cardiomyopathy 11; Dilated cardiomyopathy 1R; Atrial septal defect 5 | 2022-10-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002434316 | SCV002753758 | likely benign | Cardiovascular phenotype | 2020-01-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003396559 | SCV004122617 | likely benign | not specified | 2023-10-09 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004004353 | SCV004844851 | likely benign | Hypertrophic cardiomyopathy | 2023-10-02 | criteria provided, single submitter | clinical testing |